Hi Polly.
Rather than contact Bernard and make him re-hash. Have you spoke to him regarding the buckwheat? I would be curious to know if you have any answers to any of the below:
1) When he previously stated that the plant will not impact on project progression if this still remains the case or has the situation changed?
2) What will be the impact on the project if the plant is listed as endangered, would the project still be able to proceed on a "business as usual" basis? Would it be a big issue? Would the project have further time delays?
3) Is he confident in a resolution that is favourable for INR?
I am very surprised with all the amount of media around this that Ioneer have not made any statement to investors. Especially considering that the lithium market its horrendous at present and also that given we will be looking for finance soon, if CR is part of the plan why you wouldnt want to help support share price.
Any information on any of the above would be greatly appreciated. Thanks in advance!!
- Forums
- ASX - By Stock
- External News & Commentary
Hi Polly.Rather than contact Bernard and make him re-hash. Have...
-
- There are more pages in this discussion • 2,239 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add INR (ASX) to my watchlist
(20min delay)
|
|||||
Last
14.5¢ |
Change
0.005(3.57%) |
Mkt cap ! $338.9M |
Open | High | Low | Value | Volume |
14.5¢ | 14.5¢ | 14.0¢ | $125.7K | 871.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 812091 | 14.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.5¢ | 844808 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 812091 | 0.140 |
26 | 1764833 | 0.135 |
22 | 1865027 | 0.130 |
8 | 1207000 | 0.125 |
13 | 873992 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.145 | 844808 | 4 |
0.150 | 687787 | 9 |
0.155 | 477898 | 6 |
0.160 | 413883 | 5 |
0.165 | 281085 | 5 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
INR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online